Allometry Is a Reasonable Choice in Pediatric Drug Development.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 469, doi. 10.1002/jcph.831
- By:
- Publication type:
- Article
Works matching IS 00912700 AND DT 2017 AND VI 57 AND IP 4
Results: 15
1
2
Evaluation of Evolocumab (AMG 145), a Fully Human Anti-PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic Impairment.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 513, doi. 10.1002/jcph.832
- By:
- Publication type:
- Article
3
Oral Human Abuse Potential of Oxycodone DETERx<sup>®</sup> (Xtampza<sup>®</sup> ER).
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 500, doi. 10.1002/jcph.833
- By:
- Publication type:
- Article
4
The Pharmacokinetics of Beraprost Sodium Following Single Oral Administration to Subjects With Impaired Kidney Function.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 524, doi. 10.1002/jcph.835
- By:
- Publication type:
- Article
5
Prediction of Clearance in Neonates and Infants (≤ 3 Months of Age) for Drugs That Are Glucuronidated: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 476, doi. 10.1002/jcph.837
- By:
- Publication type:
- Article
6
Should Race-Genotype Interactions Be Considered in the Global Development of CYP2C19 Substrates? A Proposed Framework Using Physiologically Based Pharmacokinetic Modeling.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 417, doi. 10.1002/jcph.859
- By:
- Publication type:
- Article
7
Pharmacokinetics of Venetoclax, a Novel BCL-2 Inhibitor, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 484, doi. 10.1002/jcph.821
- By:
- Publication type:
- Article
8
Postmarketing Safety Events Relating to New Drugs Approved in Brazil Between 2003 and 2013: A Retrospective Cohort Study.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 493, doi. 10.1002/jcph.822
- By:
- Publication type:
- Article
9
Time Trends in Physician Visits for Gastroesophageal Reflux Disease Before and After the Rx-to-OTC Switch of Proton Pump Inhibitors.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 452, doi. 10.1002/jcph.825
- By:
- Publication type:
- Article
10
Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 459, doi. 10.1002/jcph.826
- By:
- Publication type:
- Article
11
Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 440, doi. 10.1002/jcph.828
- By:
- Publication type:
- Article
12
5-HT<sub>3</sub> Receptor Antagonists for the Prevention of Perioperative Shivering: A Meta-Analysis.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 428, doi. 10.1002/jcph.829
- By:
- Publication type:
- Article
13
Issue Information.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 411, doi. 10.1002/jcph.897
- Publication type:
- Article
14
Extracorporeal Clearance of Levetiracetam During Continuous Venovenous Hemofiltration in a Critically Ill Patient and New Dosing Recommendation.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 536, doi. 10.1002/jcph.844
- By:
- Publication type:
- Article
15
Medication Adherence.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 422, doi. 10.1002/jcph.862
- By:
- Publication type:
- Article